Abcellera Biologics Inc.盘中异动大幅拉升5.11%

自选股智能写手08-01

北京时间2024年08月01日00时54分，Abcellera Biologics Inc.（ABCL.us）股票出现异动，股价大幅上涨5.11%。截至发稿，该股报3.40美元/股，成交量101.02万股，换手率0.34%，振幅6.50%。最近的财报数据显示，该股实现营业收入9.95百万美元，净利润-40.61百万美元，每股收益-0.14美元，毛利3.19百万美元，市盈率-6.70倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2456948157?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-01 00:54","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2456948157","market":"us","top_or_hot":-1,"title":"Abcellera Biologics Inc.盘中异动 大幅拉升5.11%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年08月01日00时54分，Abcellera Biologics Inc.（ABCL.us）股票出现异动，股价大幅上涨5.11%。截至发稿，该股报3.40美元/股，成交量101.02万股，换手率0.34%，振幅6.50%。最近的财报数据显示，该股实现营业收入9.95百万美元，净利润-40.61百万美元，每股收益-0.14美元，毛利3.19百万美元，市盈率-6.70倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801005413941fca5d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Abcellera Biologics Inc.盘中异动 大幅拉升5.11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAbcellera Biologics Inc.盘中异动 大幅拉升5.11%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-01 00:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801005413941fca5d&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年08月01日00时54分，Abcellera Biologics Inc.（ABCL.us）股票出现异动，股价大幅上涨5.11%。截至发稿，该股报3.40美元/股，成交量101.02万股，换手率0.34%，振幅6.50%。最近的财报数据显示，该股实现营业收入9.95百万美元，净利润-40.61百万美元，每股收益-0.14美元，毛利3.19百万美元，市盈率-6.70倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801005413941fca5d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4535","symbol_name":"淡马锡持仓","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801005413941fca5d&s=b","article_id":"2456948157","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801005413941fca5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2456948157","pubTimestamp":1722444852,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年08月01日00时54分，Abcellera Biologics Inc.股票出现异动，股价大幅上涨5.11%。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为1.31%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一家抗体发现和开发引擎公司，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者面前。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4535":"淡马锡持仓","BK4121":"生命科学工具和服务","ABCL":"AbCellera Biologics"},"translate_title":"Abcellera Biologics Inc. jumped 5.11% in intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABCL":0.9},"content_text":"北京时间2024年08月01日00时54分，Abcellera Biologics Inc.（ABCL.us）股票出现异动，股价大幅上涨5.11%。截至发稿，该股报3.40美元/股，成交量101.02万股，换手率0.34%，振幅6.50%。最近的财报数据显示，该股实现营业收入9.95百万美元，净利润-40.61百万美元，每股收益-0.14美元，毛利3.19百万美元，市盈率-6.70倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Abcellera Biologics Inc.股票所在的生物技术行业中，整体涨幅为1.31%。其相关个股中，Molecular Partners Ag、Renovaro Inc.、木薯科学涨幅较大，Cns Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs较为活跃，换手率分别为521.34%、161.75%、141.98%，振幅较大的相关个股有Renovaro Inc.、Cns Pharmaceuticals, Inc.、Alpha Tau Medical Ltd C/Wts (To Pur Com)，振幅分别为79.10%、52.15%、44.12%。Abcellera Biologics Inc.公司简介：AbCelera Biologics Inc 是一家抗体发现和开发引擎公司，专门设计用于解决传统发现的障碍，以更高的精度和速度找到最佳的临床候选药物，更快地到达诊所和患者面前。 借助综合AbCelera平台，公司的专家可以搜索各种不同的抗体，从而快速筛选出有效和可开发的先导药物，帮助合作伙伴取得持久的成功。该公司在与新兴生物技术公司和制药公司建立合作伙伴关系方面拥有丰富的经验。 AbCelera利用专有硬件、软件和工具以及最新的数据科学，作为战略合作伙伴运营，并帮助更快地为任何项目开发优化的解决方案。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2456948157"}

Abcellera Biologics Inc.盘中异动 大幅拉升5.11%

精彩评论

Abcellera Biologics Inc.盘中异动大幅拉升5.11%